HAILEY GARRISON: Open Payments
NPI 1629590732 · POMONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,099 in 99 payments from 19 companies in 2025. Trend: 2023 $786 · 2024 $1,554 · 2025 $2,099
Food & beverage: $2,093Travel & lodging: $5
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $414 |
| Ardelyx, Inc. | 17 | $338 |
| Madrigal Pharmaceuticals | 13 | $220 |
| GENZYME CORPORATION | 5 | $207 |
| Lilly USA, LLC | 5 | $194 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $183 |
| ABBVIE INC. | 18 | $160 |
| PFIZER INC. | 5 | $124 |
| Aimmune Therapeutics, Inc. | 3 | $41 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
Products named: TREMFYA, IBSRELA, REZDIFFRA, DUPIXENT, OMVOH, XIFAXAN, RINVOQ, XELJANZ.
Industry payments across CA — which companies pay providers there.
